Skip to main content
Journal of General Internal Medicine logoLink to Journal of General Internal Medicine
. 2016 Jun 6;32(1):131–132. doi: 10.1007/s11606-016-3754-7

Silicone Breast Implant Rupture in a 70-year-old Woman Presenting with Multiple Superficial Nodules

Justin Abbatemarco 1, David Dornblaser 2, Janet Buccola 3, Rushad Patell 3,
PMCID: PMC5215145  PMID: 27271727

A 70-year-old female who had breast augmentation with silicone implants in 1988 presented with a 6-day history of new-onset multiple nodules over her abdominal wall, left groin, and arm after lifting a heavy crate. She was noted to have breast asymmetry with reduced left breast size on physical examination. Her superficial nodules were minimally erythematous, firm, and mildly tender without obvious fixation to the overlying skin or underlying tissue (Fig. 1).

Fig. 1.

Fig. 1

Anterior view of the left arm nodule

An ultrasound revealed a 7-m, heterogeneous, hypoechoic subcutaneous mass over her left arm. Computed tomography showed heterogeneous soft tissue masses containing calcified nodules representing extracapsular implant rupture with silicone leakage and tracking (Fig. 2).

Fig. 2.

Fig. 2

A computed tomography (CT) coronal view illustrating extracapsular implant rupture with silicone leakage and tracking (arrow)

Silicone breast implants are commonly used for reconstruction and augmentation. Advances in breast implant technology have reduced the incidence of implant rupture and silicone leakage and accompanying local or widespread granulomatous inflammation.1

Various other health concerns have been raised surrounding breast augmentation including cancer (breast or other) and connective tissue disease although supporting evidence is lacking.2,3 As implant rupture can be clinically silent, the US Food and Drug Administration has recommended periodic MRI scans to screen for rupture, but this is not widely accepted.4

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they do not have a conflict of interest to disclose.

References

  • 1.Brown SL, Silverman BG, Berg WA. Rupture of silicone-gel breast implants: Causes, sequelae, and diagnosis. Lancet. 1997;350(9090):1531–1537. doi: 10.1016/S0140-6736(97)03164-4. [DOI] [PubMed] [Google Scholar]
  • 2.McLaughlin JK, Lipworth L, Murphy DK, Walker PS. The safety of silicone gel-filled breast implants: A review of the epidemiologic evidence. Ann Plast Surg. 2007;59(5):569–580. doi: 10.1097/SAP.0b013e318066f0bd. [DOI] [PubMed] [Google Scholar]
  • 3.Lipworth L, Tarone RE, McLaughlin JK. Silicone breast implants and connective tissue disease: An updated review of the epidemiologic evidence. Ann Plast Surg. 2004;52(6):598–601. doi: 10.1097/01.sap.0000128087.51384.f9. [DOI] [PubMed] [Google Scholar]
  • 4.McCarthy CM, Pusic AL, Kerrigan CL. Silicone breast implants and magnetic resonance imaging screening for rupture: Do US food and drug administration recommendations reflect an evidence-based practice approach to patient care? Plast Reconstr Surg. 2008;121(4):1127–1134. doi: 10.1097/01.prs.0000302498.44244.52. [DOI] [PubMed] [Google Scholar]

Articles from Journal of General Internal Medicine are provided here courtesy of Society of General Internal Medicine

RESOURCES